drugset / Trial / NCT03553433
Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A phase 4 multicenter, randomized, placebo-controlled Study evaluating the Effect of Apremilast on Pruritus and Quality of Life of Patients with moderate-to-severe Scalp Psoriasis
Timeline
- Start
- 2018-06
- Primary completion
- 2019-12
- Completion
- 2020-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apremilast | Small molecule | 30 mg | — |